![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Diamedica Therapeutics | TSXV:DMA | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.63 | 4.57 | 5.00 | 0 | 01:00:00 |
Greencastle Resources Ltd. (TSX VENTURE:VGN) ("Greencastle" or the "Company") announces that the Company has completed a state-of-the-art detailed heli-borne magnetic and EM geophysical survey to define targets for follow up exploration on the company's Nechako property, where Greencastle has an option to acquire a 100% interest in the property, covering approximately 13,000 ha (28 claims), in the Nechako Plateau region of BC. The property is located in the same general area where Richfield Ventures Corp. is currently delineating a bulk tonnage gold deposit at its Blackwater project. Additionally, Greencastle has engaged Douglas McKay & Associates ("DMA") to provide investor relations services for the company, subject to the approval of the TSX Venture Exchange. DMA currently provides investor relations services to Richfield Ventures Corp. under a contract that expires in April, 2011. The agreement between the company and Douglas McKay & Associates provides for a monthly retainer of $5,000 for a period of one year and an option grant of one hundred and fifty thousand (150,000) options at an exercise price of $0.20, to vest according to TSX-V policy. Caution Concerning Forward-Looking Information This news release includes certain "forward looking statements" within the meaning of that phrase under Canadian securities laws. Without limitation, statements regarding potential mineralization and resources, exploration results, and future plans and objectives of the Company are forward looking statements that involve various degrees of risk. Forward-looking statements reflect management's current views with respect to possible future events and conditions and, by their nature, are based on management's beliefs and assumptions and subject to known and unknown risks and uncertainties, both general and specific to the Company. Although the Company believes the expectations expressed in such forward-looking statements are reasonable, such statements are not guarantees of future performance and actual results or developments may differ materially from those in our forward-looking statements. The following are important factors that could cause the Company's actual results to differ materially from those expressed or implied by such forward looking statements: changes in the world wide price of commodities, general market conditions, risks inherent in exploration, risks associated with development, construction and mining operations, the uncertainty of future profitability and the uncertainty of access to additional capital. Additional information regarding the material factors and assumptions that were applied in making these forward looking statements as well as the various risks and uncertainties we face are described in greater detail in the "Risk Factors" section of our annual and interim Management's Discussion and Analysis of our financial results and other continuous disclosure documents and financial statements we file with the Canadian securities regulatory authorities which are available at www.sedar.com. The Company undertakes no obligation to update this forward-looking information except as required by applicable law. The Company relies on litigation protection for forward looking statements.
1 Year DiaMedica Inc. Chart |
1 Month DiaMedica Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions